Authors


Beth Cady, PharmD, BCPS

Latest:

Top 5 Tips for Teaching ID Learners

The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.


William Alegria, PharmD, BCIDP

Latest:

Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.


Alicia Bigica

Latest:

Maternal COVID-19 Vaccination, Infection Boosts Infant Antibody Response

Natural infection plus COVID-19 vaccination in pregnant mothers conferred more durable antibody responses in infants than natural infection alone.


Inessa Gendlina, MD

Latest:

What to Expect With Influenza in the Era of COVID-19

Here are some insights into this upcoming 2021-2022 influenza season as well as concerns of the twindemic and addressing both the seasonal and pandemic viruses simultaneously.


Sean N Tucker, PhD

Latest:

Vaxart's Oral Norovirus Vaccine: Key Study Findings and Future Plans

Sean Tucker, PhD, highlights effective immune response and mucosal immunity, paving the way for broader applications in viral disease prevention.


Judith Lee, MSN, CRNP, AACRN

Latest:

HIV and Aging in the Era of Antiretroviral Therapy: Considerations in Clinical Care

With the population of adults with HIV growing older, incorporating age-based screenings, comprehensive assessments, and morbidity management into routine HIV care is essential in improving health outcomes and quality of life.


James Wilson, DO

Latest:

Nonventilator Hospital-Acquired Pneumonia: Epidemiology, Prevention, and Where It Is Now

The management of hospital-acquired pneumonia requires use of preventive bundles, mitigative of risk factors, and prompt diagnosis with initiation of treatment when highly suspected.



Svetlana Blitshteyn, MD, FAAN

Latest:

What We Know But Still Have to Learn About Long COVID

Despite advances in understanding and treating Long COVID, many questions about its mechanisms, susceptibility, and varied recovery patterns remain unresolved, underscoring the need for continued research.


David Wohl, MD

Latest:

The Importance to Address and Help Visceral Adiposity in HIV Patients

David Wohl, MD, explains the health risks of visceral fat and the role of treatments like Tesamorelin F8 in managing the condition.


Yingsi(Vincy) Fang, PharmD, BSC

Latest:

Do We Have New Data for Optimal Treatments of Candida-Related Prosthetic Joint Infections?

The choice between debridement and implant exchange affects treatment outcomes for Candida-related prosthetic joint infections, highlighting the need for standardized guidelines and further research.


Aiman Bandali, PharmD, AAHIVP, BCPS, BCIDP

Latest:

Clinical Considerations in Conducting Antifungal Susceptibility Testing

Access to antifungal susceptibility testing (AFST) remains limited in the United States. Therefore, providers must recognize clinical situations where AFST will provide its greatest value. In the latest article from SIDP, infectious disease pharmacists offers some insights on this subject.


Zoheir Khan, MD; and Jeremy L. Agostinho, MD

Latest:

A Case of Mycobacterium Chimaera Infective Endocarditis

Nonspecific, nondolent symptoms make this disease difficult to diagnose.


Leah Rodriguez, PharmD

Latest:

A Review of the Currently Available Monoclonal Antibodies for COVID-19

Outside of vaccines, these underutilized therapies are the best defense against severe disease.


Society of Infectious Diseases Pharmacists

Latest:

Celebrating 30 Years: The Past, Present, and Future of the Society of Infectious Diseases Pharmacists (SIDP)

Introducing “Bench to Bedside With SIDP,” a new column covering everything from antimicrobial stewardship and pharmacokinetics/pharmacodynamics to mentorship, preceptorship, and more.


Joseph Osmundson, PhD

Latest:

A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect

Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.


Anushua Sinha, MD

Latest:

Merck's Clesrovimab Shows Effectiveness in RSV Prevention for Infants

Anushua Sinha, MD, discussed the findings, highlighting a 60.4% reduction in medically attended lower respiratory infections and significant decreases in RSV-related hospitalizations.


Mustafeez Babar, PharmD, MPhil, PhD

Latest:

SPREADing the Love: The Importance of Mentorship in Pharmacy

In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.


Shauna Applin, ARNP

Latest:

Restarting Therapy in Patients with HIV

Addressing patients with HIV who have fallen out of care, Shauna Applin, ARNP, provides clinical insights on treatment options and best practices for restarting therapy.


Laura Walters, DO

Latest:

Tuberculosis Meningitis in an Immunocompetent Patient

Read more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.


Matthew D. Sims, MD, PhD, FACP, FIDSA

Latest:

Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile Infections

To close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.


Andrew Aronsohn, MD

Latest:

AASLD/IDSA Develop a New Algorithm for Hepatitis C Point of Care Testing and Treatment

Andrew Aronsohn, MD, associate professor of Medicine, University of Chicago Medical Center, discusses the hepatitis C (HCV) screen and treat plan that looks to utilize a one visit approach to get people tested and on medication in the same patient encounter.


Andrew R. Motzer, MD

Latest:

A Case of Varicella-Zoster Meningitis Causing Postoperative Fevers After Umbilical Hernia Repair

Due to worsening headaches and unrevealing cross-sectional imaging and ascites fluid analyses, this patient's differential evolved toward a central nervous system source.


Patrick McDaneld, PharmD, BCIDP

Latest:

Are We at a Breaking Point for Adoption of Updated Susceptibility Interpretive Criteria?

The implementation of new College of American Pathologists rules presents an opportunity for collaboration between clinical microbiology laboratories and infectious disease pharmacists and physicians.



Allison Cid, PharmD

Latest:

Ceftriaxone Dosing: Once or Twice Daily?

In the latest column from SIDP, clinicians discuss that along with the once-daily dosing for many indications, there are also compelling indications for twice-daily dosing.



Diane Shader Smith

Latest:

Honoring Her Daughter’s Legacy After a Long-Standing Battle With Antimicrobial Resistance

After Diane Shader Smith lost her daughter, Mallory, to a multidrug resistant infection, she turned her personal tragedy into a mission designed to inform people about antimicrobial resistance (AMR), and have the public coalesce around this expanding medical issue.


Chris Baker

Latest:

Ethical and Innovative Use of AI in Infectious Disease

Patient-centered innovation amidst evolving regulations and policies is a key strategy.


Emily Ricotta, PhD, MSc

Latest:

Strengthening Observational Studies: Community Engagement and Data Practices

Emily Ricotta, PhD, MSc outlines the importance of involving affected populations and refining data collection methods to improve early decision-making during epidemics

© 2025 MJH Life Sciences

All rights reserved.